| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.95 | 0.004 | 0.95 | Toll-Like receptor agonist | 0.403 0.059 CHEMBL3526875 | ||
| 0.949 | 0.004 | 0.949 | Toll-Like receptor 7 agonist | 0.407 0.057 CHEMBL3526875 | ||
| 0.881 | 0.004 | 0.881 | Lipoxygenase inhibitor | 0.201 0.139 CHEMBL3526875 | ||
| 0.787 | 0.002 | 0.787 | 5-Lipoxygenase inhibitor | |||
| 0.779 | 0.002 | 0.779 | Leukotriene synthesis inhibitor | 0.066 0.048 CHEMBL3526875 | ||
| 0.691 | 0.014 | 0.691 | Analgesic | |||
| 0.66 | 0.038 | 0.66 | Antiinflammatory | |||
| 0.42 | 0.102 | 0.42 | Transcription factor inhibitor | |||
| 0.366 | 0.08 | 0.402 | Antiobesity | 0.402 0.065 CHEMBL3526875 | CHEMBL3526875 | |
| 0.33 | 0.068 | 0.33 | Streptokinase A inhibitor | 0.166 0.158 CHEMBL3526875 | ||
| 0.19 | 0.004 | 0.19 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.163 | 0.015 | 0.163 | CDK2/cyclin E2 inhibitor | |||
| 0.129 | 0.005 | 0.129 | Liver X receptor agonist | |||
| 0.202 | 0.093 | 0.202 | Hypolipemic | 0.178 0.111 CHEMBL3526875 | ||
| 0.141 | 0.043 | 0.168 | Papain-like protease (SARS coronavirus) inhibitor | 0.168 0.021 CHEMBL3526875 | CHEMBL3526875 | |
| 0.089 | 0.005 | 0.089 | Liver X receptor antagonist | |||
| 0.052 | 0.005 | 0.052 | Liver X receptor alpha antagonist | |||
| 0.049 | 0.02 | 0.049 | Liver X receptor alpha agonist | |||
| 0.04 | 0.015 | 0.04 | Liver X receptor beta agonist | |||
| 0.058 | 0.035 | 0.058 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR group II) agonist | |||
| 0.036 | 0.02 | 0.036 | Glutamate (mGluR2) agonist | |||
| 0.07 | 0.054 | 0.07 | Lipase inhibitor | |||
| 0.022 | 0.007 | 0.023 | Potassium channel (Inward rectifier) 11 blocker | 0.023 0.006 CHEMBL3526875 | CHEMBL3526875 | |
| 0.087 | 0.072 | 0.087 | ABCA1 expression enhancer | |||
| 0.107 | 0.095 | 0.107 | Cyclooxygenase 2 inhibitor | |||
| 0.049 | 0.037 | 0.049 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.05 | 0.042 | 0.05 | Acetyl-CoA transferase inhibitor | |||
| 0.227 | 0.239 | 0.378 | Cyclophilin D inhibitor | 0.378 0.103 CHEMBL3526875 | CHEMBL3526875 | |
| 0.068 | 0.081 | 0.091 | Androgen antagonist | 0.091 0.054 CHEMBL3526875 | CHEMBL3526875 | |
| 0.031 | 0.076 | 0.151 | Mineralocorticoid receptor antagonist | 0.151 0.005 CHEMBL3526875 | CHEMBL3526875 | |
| 0.113 | 0.16 | 0.152 | Anesthetic general | 0.152 0.112 CHEMBL3526875 | CHEMBL3526875 | |
| 0.013 | 0.068 | 0.071 | Glucocorticoid antagonist | 0.071 0.008 CHEMBL3526875 | CHEMBL3526875 | |
| 0.178 | 0.242 | 0.214 | Ca(v)3.3 blocker | 0.214 0.163 CHEMBL3526875 | CHEMBL3526875 | |
| 0.004 | 0.083 | 0.04 | Glucocorticoid agonist | 0.04 0.005 CHEMBL3526875 | CHEMBL3526875 | |
| 0.062 | 0.215 | 0.105 | Estrogen antagonist | 0.105 0.086 CHEMBL3526875 | CHEMBL3526875 | |
| 0.045 | 0.233 | 0.096 | Estrogen receptor beta antagonist | 0.096 0.072 CHEMBL3526875 | CHEMBL3526875 | |
| 0.072 | 0.274 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.084 CHEMBL3526875 | CHEMBL3526875 | |
| 0.051 | 0.433 | 0.328 | Alpha-glucosidase inhibitor | 0.328 0.147 CHEMBL3526875 | CHEMBL3526875 | |
| 0.002 | 0.43 | 0.024 | KiSS-1 receptor antagonist | 0.024 0.007 CHEMBL3526875 | CHEMBL3526875 | |
| 0.019 | 0.501 | 0.046 | Parathyroid hormone antagonist | 0.046 0.029 CHEMBL3526875 | CHEMBL3526875 | |
| 0.001 | 0.487 | 0.009 | KiSS-1 receptor agonist | 0.009 0.007 CHEMBL3526875 | CHEMBL3526875 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |